Recall Record

Newark, NJ, United States

Pharmaceutical Innovations, Inc. recalls

2 recalls recorded since 2018, most recently on 13 August 2020. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls2
Ongoing (FDA)0
Terminated or completed2
Class I (FDA)0

Terminated Class II Medical devices

Recall started
13 August 2020
Terminated
16 September 2021
Reason
The firm registered the product as a Class I device, but has since been informed by FDA that the device is not Class I and requires a 510(k) submission.
Distribution
US Nationwide distribution including in the state of Nevada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2830-2020

Terminated Class II Medical devices

Recall started
19 June 2019
Terminated
29 July 2020
Reason
Potential for failed stability antimicrobial effectiveness testing.
Distribution
US nationwide distribution including the states of AZ, CA, CT, FL, IL, MA, MI, MN, NC, NJ, NY, OH, PA, RI, TX, TN, VT, WV. Distributed Internationally to accounts in Australia, France, Germany, Hong Kong, Saudi Arabia and Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1969-2019, Z-1972-2019, Z-1970-2019, Z-1971-2019, Z-1968-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.